Warren Shawn Carbonell
Chief Scientific Officer at OncoSynergy
Greater Seattle Area
Overview
Work Experience
Founder
2025 - Current
Cofounder & Managing Partner
2021
Academia sucks. Start a startup. Funding the rising generation of scientist-CEOs.
Brazen Capital is a venture capital fund.
Cofounder & CEO
2021
Building community for the rising generation of scientist-CEOs
Brazen Bio helps scientists spin their research out of labs and into the private markets.
Cofounder & President
2019
Building awareness and solutions for brain cancer.
Operations
2025 - 2025
Chief Clown Operator at The New Jersey Fives Premier Level Major League Pickleball team founded in 2022 by Gary Vaynerchuk and Ryan Harwood. 🖐🏽🤡🥒
Cofounder & Chief Scientific Officer
2022 - 2025
Invented and developed the world's first clinical stage beta1 integrin therapeutic, OS2966.
OncoSynergy improves outcomes for patients with unmet needs in oncology with resistance mechanism inhibitors.
Raised $23,256,575.00 from Connecticut Innovations, NLabs and Korea Information & Communication Co..
Cofounder & CEO
2011 - 2019
Inventor and developer of the first ever clinical stage beta1 integrin therapeutic, OS2966.
OncoSynergy improves outcomes for patients with unmet needs in oncology with resistance mechanism inhibitors.
Raised $23,256,575.00 from Connecticut Innovations, NLabs and Korea Information & Communication Co..
Postdoctoral Scholar, Department of Neurological Surgery
2010 - 2012
Studied the role of beta1 integrin in driving therapy resistance in glioblastoma in the Brain Tumor Research Center (BTRC)
Nicholas Kurti Junior Fellow in Science
2007 - 2010
Demonstrated the key role of beta1 integrin in the establishment and progression of brain metastases.
Senior Postdoctoral Fellow
2006 - 2009
Senior Postdoctoral Researcher supported by Cancer Research UK. Established and was a lead investigator of the brain metastasis research program in the Department of Radiation Oncology and Biology at the University of Oxford, UK.
Neurosurgery Resident
2009 - 2009
Cedars-Sinai Health Ventures is a venture capital firm.